Search research articles
Contact Us
Filters
Showing results (391-400 of 434) with videos related to
Page
of 44
Sort By:
Blood
|
August 13, 2017
Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets
Alyssa Bouska, Chengfeng Bi, Waseem Lone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 3, 2019
Dose-Adjusted EPOCH-R Compared With R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase III Intergroup Trial Alliance/CALGB 50303
Nancy L Bartlett, Wyndham H Wilson, Sin-Ho Jung, et al.
Blood
|
December 16, 2014
Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma
Javeed Iqbal, Yulei Shen, Xin Huang, et al.
Blood Cancer Discovery
|
November 15, 2021
Overcoming Acquired Epigenetic Resistance to BTK Inhibitors
Arthur L Shaffer, James D Phelan, James Q Wang, et al.
Blood
|
September 29, 2019
Reproducing the molecular subclassification of peripheral T-cell lymphoma-NOS by immunohistochemistry
Catalina Amador, Timothy C Greiner, Tayla B Heavican, et al.
Cancer Cell
|
January 12, 2024
Response to Bruton's tyrosine kinase inhibitors in aggressive lymphomas linked to chronic selective autophagy
James D Phelan, Sebastian Scheich, Jaewoo Choi, et al.
Blood
|
July 28, 2005
Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction
Silvia Bea, Andreas Zettl, George Wright, et al.
Blood
|
April 7, 2016
B-cell-specific conditional expression of Myd88p.L252P leads to the development of diffuse large B-cell lymphoma in mice
Gero Knittel, Paul Liedgens, Darya Korovkina, et al.
Blood
|
June 19, 2008
Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study
Ken H Young, Karen Leroy, Michael B Møller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 2, 2012
Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone
Nathalie A Johnson, Graham W Slack, Kerry J Savage, et al.
Page
of 44
Search research articles
Search
Showing results (391-400 of 434) with videos related to
Sort By:
Page
of 44
Blood
|
August 13, 2017
Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets
Alyssa Bouska, Chengfeng Bi, Waseem Lone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 3, 2019
Dose-Adjusted EPOCH-R Compared With R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase III Intergroup Trial Alliance/CALGB 50303
Nancy L Bartlett, Wyndham H Wilson, Sin-Ho Jung, et al.
Blood
|
December 16, 2014
Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma
Javeed Iqbal, Yulei Shen, Xin Huang, et al.
Blood Cancer Discovery
|
November 15, 2021
Overcoming Acquired Epigenetic Resistance to BTK Inhibitors
Arthur L Shaffer, James D Phelan, James Q Wang, et al.
Blood
|
September 29, 2019
Reproducing the molecular subclassification of peripheral T-cell lymphoma-NOS by immunohistochemistry
Catalina Amador, Timothy C Greiner, Tayla B Heavican, et al.
Cancer Cell
|
January 12, 2024
Response to Bruton's tyrosine kinase inhibitors in aggressive lymphomas linked to chronic selective autophagy
James D Phelan, Sebastian Scheich, Jaewoo Choi, et al.
Blood
|
July 28, 2005
Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction
Silvia Bea, Andreas Zettl, George Wright, et al.
Blood
|
April 7, 2016
B-cell-specific conditional expression of Myd88p.L252P leads to the development of diffuse large B-cell lymphoma in mice
Gero Knittel, Paul Liedgens, Darya Korovkina, et al.
Blood
|
June 19, 2008
Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study
Ken H Young, Karen Leroy, Michael B Møller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 2, 2012
Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone
Nathalie A Johnson, Graham W Slack, Kerry J Savage, et al.
Page
of 44